Noriomi Kuroki
Overview
Explore the profile of Noriomi Kuroki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arakawa I, Kuroki N, Takahashi H, Okada T
Crim Behav Ment Health
. 2025 Feb;
PMID: 39977378
Background: Treatment goals for offenders with mental disorders include restoring and maintaining health, establishing social participation and preventing negative outcomes, including further offending. The development of patient insight into their...
2.
Arakawa I, Sekiguchi Y, Takeda K, Watanabe K, Kuroki N, Kono T, et al.
PCN Rep
. 2024 Jun;
2(3):e134.
PMID: 38867820
Aim: Treating individuals with a mental disorder and a history of criminal behavior (mentally disordered offenders [MDOs]) aims to enable patients to maintain their health and facilitate social rehabilitation while...
3.
Kinoshita H, Kuroki N, Okada T
Front Psychiatry
. 2021 Jul;
12:600456.
PMID: 34290626
This study assessed the hypothesis that violent behavior prior to admission prolongs psychiatric hospitalization and evaluated the likelihood of hospital discharge to a community care setting based on demographic and...
4.
Kuroki N, Kashiwagi H, Ota M, Ishikawa M, Kunugi H, Sato N, et al.
BMC Psychiatry
. 2017 Apr;
17(1):136.
PMID: 28403847
No abstract available.
5.
Kuroki N, Kashiwagi H, Ota M, Ishikawa M, Kunugi H, Sato N, et al.
BMC Psychiatry
. 2017 Mar;
17(1):105.
PMID: 28327107
Background: The biological underpinnings of serious violent behaviors in patients with schizophrenia remain unclear. The aim of this study was to identify the characteristics of brain morphometry in patients with...
6.
Nishinaka H, Nakane J, Nagata T, Imai A, Kuroki N, Sakikawa N, et al.
PLoS One
. 2016 Jan;
11(1):e0148354.
PMID: 26824701
Background: In Japan, the legislation directing treatment of offenders with psychiatric disorders was enacted in 2005. Neuropsychological impairment is highly related to functional outcomes in patients with psychiatric disorders, and...
7.
Kashiwagi H, Kuroki N, Ikezawa S, Matsushita M, Ishikawa M, Nakagome K, et al.
Ann Gen Psychiatry
. 2015 Dec;
14:46.
PMID: 26697100
Background: The relationship between violence and neurocognitive function in schizophrenia is unclear. We examined the backgrounds and neurocognitive functions of violent and nonviolent patients with schizophrenia to identify factors associated...
8.
Davidson C, Kuroki N, Alvarado J, Niznikiewicz M, McCarley R, Levitt J
Schizophr Res
. 2011 Dec;
134(2-3):165-70.
PMID: 22177349
Septum pellucidum (SP) and cavum SP (CSP) were delineated in two samples. The Longitudinal Study examined structural MR-images in first-episode schizophrenia (FESZ) and controls at two time-points. The Cross-Sectional Study...
9.
Yamashita H, Yoda H, Kuroki N, Kuwabara M, Odagaki Y, Kazawa T, et al.
Psychopharmacology (Berl)
. 2010 Sep;
213(1):1-9.
PMID: 20820759
Rationale: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance. Objectives:...
10.
Salisbury D, Kuroki N, Kasai K, Shenton M, McCarley R
Arch Gen Psychiatry
. 2007 May;
64(5):521-9.
PMID: 17485604
Context: Progressive brain abnormalities in schizophrenia remain controversial. Evidence of interrelated progressive functional impairment would buttress the case for structural progression. Mismatch negativity (MMN) is reduced in chronic but not...